Literature DB >> 12403371

Ambulatory blood pressure monitoring in children and adolescents.

Ari M Simckes1, Tarak Srivastava, Uri S Alon.   

Abstract

With recent technological advances, 24-hour ambulatory blood pressure (BP) monitoring (ABPM) has become a useful tool for the evaluation, diagnosis, and management of hypertensive children. It provides a more accurate representation of an individual's BP rather than intermittent casual or office BP measurements. Hence, ABPM is being used more often to assess the BP of children. In this comprehensive review, we provide the reader with the available literature on ABPM, discuss the advantages and limitations of ABPM, and the interpretation of ABPM data. The role of ABPM in various clinical conditions and hypertension research in children is presented.

Entities:  

Mesh:

Year:  2002        PMID: 12403371     DOI: 10.1177/000992280204100801

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  5 in total

1.  Ambulatory blood pressure in children with diabetes 1.

Authors:  Tereza Suláková; Jan Janda
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

Review 2.  A diagnostic approach for the child with hypertension.

Authors:  Natasa Marcun Varda; Alojz Gregoric
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

3.  Twenty-four-hour ambulatory blood pressure monitoring in infants and toddlers.

Authors:  Natasa Marcun Varda; Alojz Gregoric
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

4.  Agreement on reporting of ambulatory blood pressure monitoring in children.

Authors:  Sean E Kennedy; Fiona E Mackie; Andrew R Rosenberg; Elizabeth Craig; Gad Kainer
Journal:  Pediatr Nephrol       Date:  2005-10-14       Impact factor: 3.714

5.  Blood pressure load, proteinuria and renal function in pre-hypertensive children.

Authors:  Riccardo Lubrano; Elisabetta Travasso; Claudia Raggi; Giuliana Guido; Raffaele Masciangelo; Marco Elli
Journal:  Pediatr Nephrol       Date:  2008-12-19       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.